Search Results - "Gibson, Sheila"

Refine Results
  1. 1

    Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys by Chang, Shu-Ching, Noker, Patricia E., Gorman, Gregory S., Gibson, Sheila J., Hart, Jill A., Ehresman, David J., Butenhoff, John L.

    Published in Reproductive toxicology (Elmsford, N.Y.) (01-07-2012)
    “…► Perfluorooctanesulfonate is found in biological samples from wildlife and humans. ► Pharmacokinetic parameters for PFOS in rats, mice, and monkeys were…”
    Get full text
    Journal Article
  2. 2

    Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 by Gorden, Keith B, Gorski, Kevin S, Gibson, Sheila J, Kedl, Ross M, Kieper, William C, Qiu, Xiaohong, Tomai, Mark A, Alkan, Sefik S, Vasilakos, John P

    Published in The Journal of immunology (1950) (01-02-2005)
    “…Although TLR7 and TLR8 are phylogenetically and structurally related, their relative functions are largely unknown. The role of TLR7 has been established using…”
    Get full text
    Journal Article
  3. 3
  4. 4

    TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN by Inglefield, Jon R, Dumitru, Calin Dan, Alkan, Sefik S, Gibson, Sheila J, Lipson, Kenneth E, Tomai, Mark A, Larson, Chris J, Vasilakos, John P

    Published in Journal of interferon & cytokine research (01-04-2008)
    “…Antitumor effects of the toll-like receptor 7 (TLR7) agonist, 852A, were evaluated. Supernatants from human peripheral blood mononuclear cells (PBMC)…”
    Get more information
    Journal Article
  5. 5

    Reconstructing the Serapeum in Alexandria from the Archaeological Evidence by McKenzie, Judith S., Gibson, Sheila, Reyes, A. T., Grimm, Günter, McKenzie, Judith S.

    Published in The Journal of Roman studies (01-11-2004)
    “…The Serapeum or Sarapeion, which contained the Temple of Serapis, was Alexandria's most important sanctuary, and one of the most famous pagan sanctuaries of…”
    Get full text
    Journal Article
  6. 6

    Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation by Murgatroyd, F D, Gibson, S M, Baiyan, X, O'Nunain, S, Poloniecki, J D, Ward, D E, Malik, M, Camm, A J

    Published in Circulation (New York, N.Y.) (01-06-1999)
    “…Digoxin is commonly prescribed in symptomatic paroxysmal atrial fibrillation (AF) but has never been evaluated in this condition. From a multicenter registry,…”
    Get full text
    Journal Article
  7. 7

    Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry by Inglefield, Jon R, Larson, Christopher J, Gibson, Sheila J, Lebrec, Hervé, Miller, Richard L

    Published in Journal of biomolecular screening (01-09-2006)
    “…The authors describe an assay to quantitate DNA fragmentation using terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling…”
    Get more information
    Journal Article
  8. 8

    Cytokine induction by the immunomodulators imiquimod and S-27609 by Testerman, T L, Gerster, J F, Imbertson, L M, Reiter, M J, Miller, R L, Gibson, S J, Wagner, T L, Tomai, M A

    Published in Journal of leukocyte biology (01-09-1995)
    “…Imiquimod (R-837, S-26308) and the analogue S-27609 were evaluated for cytokine induction in human blood cells. Both compounds induced interferon-alpha (IFN),…”
    Get more information
    Journal Article
  9. 9

    Water fluoridation by Jones, Graeme, Connett, Paul, Gibson, Sheila L. M., Gibson, Robin G., Holloway, P. J., McDonagh, Marian S., Kleijnen, Jos, Schmidt, T. C., Phipps, Kathy, Orwoll, Eric, Mason, Jill, Cauley, Jane, Baldwin of Bewdley, Auley, Don Mac

    Published in BMJ (16-06-2001)
    “…Jun 1, 2001 EDITOR-The systematic review by McDonagh et al indicates that the benefits and risks of water fluoridation balance each other in that a median of…”
    Get full text
    Journal Article
  10. 10

    Toll-like receptor (TLR) 2–9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses by Ghosh, Tarun K., Mickelson, Dan J., Fink, Jason, Solberg, Jonathan C., Inglefield, Jon R., Hook, Derek, Gupta, Shalley K., Gibson, Sheila, Alkan, Sefik S.

    Published in Cellular immunology (01-09-2006)
    “…The cells of innate and adaptive immunity, although activated by different ligands, engage in cross talk to ensure a successful immune outcome. To better…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Water fluoridation and tooth decay in 5 year olds by Vemmer, Tiemo, Gibson, Sheila L. M., Gibson, Robin G., Jones, Colwyn, Taylor, Geoff, Evans, David, Whittle, Gary, Trotter, David

    Published in BMJ (17-01-1998)
    “…[...]Jones et al do not state whether the populations of the different wards were comparable or whether less privileged areas had a higher proportion than did…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and Imiquimod by Wagner, Tamara L., Ahonen, Cory L., Couture, Aimee M., Gibson, Sheila J., Miller, Richard L., Smith, Rose M., Reiter, Michael J., Vasilakos, John P., Tomai, Mark A.

    Published in Cellular immunology (10-01-1999)
    “…Cytokines produced by antigen-presenting cells are known to affect the development and cytokine profile of T cells. The immune response modifiers imiquimod and…”
    Get full text
    Journal Article
  15. 15

    Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN by Vasilakos, John P., Smith, Rose M.A., Gibson, Sheila J., Lindh, Jana M., Pederson, Linda K., Reiter, Michael J., Smith, Michael H., Tomai, Mark A.

    Published in Cellular immunology (25-08-2000)
    “…R-848 and imiquimod belong to a class of immune response modifiers that are potent inducers of cytokines, including IFN-α, TNF-α, IL-12, and IFN-γ. Many of…”
    Get full text
    Journal Article
  16. 16

    Cytokine Induction in Hairless Mouse and Rat Skin After Topical Application of the Immune Response Modifiers Imiquimod and S-28463 by Imbertson, Linda M., Couture, Aimee M., Gibson, Sheila J., Smith, Rose M.A., Miller, Richard L., Reiter, Michael J., Wagner, Tamara L., Tomai, Mark A., Beaurline, Joseph M.

    Published in Journal of investigative dermatology (01-05-1998)
    “…ALDARA (imiquimod cream 5%) recently became available for the treatment of genital and perianal warts; however, the topical mechanism of action of imiquimod is…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Dendritic Cell Maturation and Subsequent Enhanced T-Cell Stimulation Induced with the Novel Synthetic Immune Response Modifier R-848 by Ahonen, Cory L., Gibson, Sheila J., Smith, Rose M., Pederson, Linda K., Lindh, Jana M., Tomai, Mark A., Vasilakos, John P.

    Published in Cellular immunology (10-10-1999)
    “…Agents that enhance dendritic cell maturation can enhance T-cell activation and therefore may improve the efficiency of vaccines or improve cellular…”
    Get full text
    Journal Article
  19. 19
  20. 20